← All causality assessments
Causality assessment · Causality: well established

Efavirenz and Suicidal depression: is the FAERS signal real?

n=36 co-reports · PRR 19.9 · ROR 19.9
A written Bradford Hill assessment of one drug–event pair. The grade is a judgement about the signal, not a statement that this drug causes this event in any one person; FAERS counts are reports, not rates.
Causality: well established

Efavirenz ↔ Suicidal depression

n=36 co-reports · PRR 19.9 · ROR 19.9

Efavirenz carries a boxed warning for serious psychiatric symptoms including depression and suicidality, which can occur at any time during therapy; 36 co-reports give PRR 19.9. Patients are warned to report mood change, and the drug is stopped if symptoms are severe.

Regulatory basis: efavirenz (Sustiva) prescribing information — boxed warning for psychiatric symptoms and suicidality.

Bradford Hill viewpointStatusNote
Temporality (necessary)metAny time on therapy
StrengthmetPRR 19.9 with 36 co-reports
ConsistencymetReproduced across cohorts
Specificitynot establishedDepression is common in the population
Biological gradientnot establishedNot clearly dose-related
PlausibilitymetPlausible CNS mechanism
CoherencemetFits efavirenz neuropsychiatric effects
Experimentn/aRarely coded as a trial endpoint
AnalogymetAnalogous to other antiretroviral CNS effects

This table is this page's own qualitative read of the literature cited above, not an automated or citation-gated assessment — see the note at the bottom of this page.

✗ No ClinicalTrials.gov results-posting trial in the top search hits for efavirenz captured suicidal depression as a tracked adverse event in a usable structure. Trials under-reported psychiatric adverse events and coded suicidality poorly.